This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
n10http://linked.opendata.cz/resource/drugbank/drug/DB02145/identifier/pdb/
n13http://linked.opendata.cz/resource/drugbank/drug/DB02145/identifier/kegg-compound/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB02145/identifier/pubchem-compound/
n14http://linked.opendata.cz/resource/drugbank/drug/DB02145/identifier/kegg-drug/
n7http://linked.opendata.cz/resource/drugbank/drug/DB02145/identifier/pubchem-substance/
n16http://linked.opendata.cz/resource/drugbank/drug/DB02145/identifier/drugbank/
n17http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n9http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n15http://linked.opendata.cz/resource/drugbank/drug/DB02145/identifier/chemspider/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n12http://linked.opendata.cz/resource/drugbank/drug/DB02145/identifier/chebi/
n4http://linked.opendata.cz/ontology/drugbank/
n5http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#

Statements

Subject Item
n2:DB02145
rdf:type
n4:Drug
n4:group
experimental
owl:sameAs
n9:DB02145 n17:DB02145
dcterms:title
Butan-1-Ol
adms:identifier
n7:46507086 n10:1BO n11:263 n12:28885 n13:C06142 n14:D03200 n15:258 n16:DB02145
n4:synthesisReference
Howard H. Chou, Jay D. Keasling, "Host Cells and Methods for Producing 3-Methyl-2-buten-1-ol, 3-Methyl-3-buten-1-ol, and 3-Methyl-butan-1-ol." U.S. Patent US20100205855, issued August 19, 2010.
n4:IUPAC-Name
n5:271B4219-363D-11E5-9242-09173F13E4C5
n4:InChI
n5:271B421F-363D-11E5-9242-09173F13E4C5
n4:Molecular-Formula
n5:271B421E-363D-11E5-9242-09173F13E4C5
n4:Molecular-Weight
n5:271B421B-363D-11E5-9242-09173F13E4C5
n4:Monoisotopic-Weight
n5:271B421C-363D-11E5-9242-09173F13E4C5
n4:SMILES
n5:271B421D-363D-11E5-9242-09173F13E4C5
n4:Water-Solubility
n5:271B422F-363D-11E5-9242-09173F13E4C5 n5:271B4217-363D-11E5-9242-09173F13E4C5
n4:logP
n5:271B4218-363D-11E5-9242-09173F13E4C5 n5:271B4215-363D-11E5-9242-09173F13E4C5 n5:271B4232-363D-11E5-9242-09173F13E4C5
n4:logS
n5:271B4216-363D-11E5-9242-09173F13E4C5
n4:pKa
n5:271B4233-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Acceptor-Count
n5:271B4225-363D-11E5-9242-09173F13E4C5
n4:H-Bond-Donor-Count
n5:271B4226-363D-11E5-9242-09173F13E4C5
n4:InChIKey
n5:271B4220-363D-11E5-9242-09173F13E4C5
n4:Polar-Surface-Area--PSA-
n5:271B4221-363D-11E5-9242-09173F13E4C5
n4:Polarizability
n5:271B4223-363D-11E5-9242-09173F13E4C5
n4:Refractivity
n5:271B4222-363D-11E5-9242-09173F13E4C5
n4:Rotatable-Bond-Count
n5:271B4224-363D-11E5-9242-09173F13E4C5
n4:casRegistryNumber
71-36-3
n4:Bioavailability
n5:271B422B-363D-11E5-9242-09173F13E4C5
n4:Boiling-Point
n5:271B4231-363D-11E5-9242-09173F13E4C5
n4:Ghose-Filter
n5:271B422D-363D-11E5-9242-09173F13E4C5
n4:MDDR-Like-Rule
n5:271B422E-363D-11E5-9242-09173F13E4C5
n4:Melting-Point
n5:271B4230-363D-11E5-9242-09173F13E4C5
n4:Number-of-Rings
n5:271B422A-363D-11E5-9242-09173F13E4C5
n4:Physiological-Charge
n5:271B4229-363D-11E5-9242-09173F13E4C5
n4:Rule-of-Five
n5:271B422C-363D-11E5-9242-09173F13E4C5
n4:Traditional-IUPAC-Name
n5:271B421A-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-acidic-
n5:271B4227-363D-11E5-9242-09173F13E4C5
n4:pKa--strongest-basic-
n5:271B4228-363D-11E5-9242-09173F13E4C5